Chemical analyses and X-ray diffraction investigations of human hydroxyapatite minerals from aortic valve stenoses

Zeitschrift fur Kristallographie

Volumn 220, Issue 2-3, 2005, Pages 201-205

  Stork, Ludwig ^a   Müller, Paul ^a   Dronskowski, Richard ^a   Ortlepp, Jan R ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Atomic absorption spectroscopy; Human hydroxyapatite; Pathological biomineralization; Powder diffraction structure analysis; Rietveld refinement; X ray diffraction

Indexed keywords

HYDROXYAPATITE; MINERAL;

AORTA VALVE DISEASE; AORTA VALVE STENOSIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CALCIUM METABOLISM; CHEMICAL ANALYSIS; CRYSTAL STRUCTURE; CRYSTALLIZATION; GEOMETRY; HUMAN; HUMAN TISSUE; MINERALIZATION; STRUCTURE ANALYSIS; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

EID: 14844313753     PISSN: 00442968     EISSN: None     Source Type: Journal    
DOI: 10.1524/zkri.220.2.201.59118     Document Type: Article

References (13)

1. Ross, J.; Braunwald, E.: Aortic Stenosis. Circulation 38 (1 Suppl.) (1968) 61-67.
2. Lindroos, M.; Kupari, M.; Heikkila, J.; Tilvis, R.: Prevalence of aortic abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21 (1993) 1220-1225.
3. Stewart, B. F.; Siscovick, D.; Lind, B. K.; Gardin, J. M.; Gottdiener, J. S.; Smith, V. E.; Kitzman, D. W.; Otto, C. M.: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29 (1997) 630-634.
4. Otto, C. M.; Lind, B. K.; Kitzman, D. E.; Gersh, B. J.; Siscovick, D. S.: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Engl. J. Med. 341 (1999) 142-147.
5. Stefenelli, X; Mayr, H.; Bergler-Klein, J.; Globits, S.; Woloszczuk, W.; Niederle, B.: Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med. 95 (1993) 197-202.
6. Maher, E. R.; Young, G.; Smyth-Walsh, B.; Pugh, S.; Curtis J. R.: Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2 (1987) 875-877.
7. Ortlepp, J. R.; Hoffmann, R.; Ohme, F.; Lauscher, J.; Bleckmann, F.; Hanrath, P.: The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85 (2001) 639-642.
8. Ortlepp, J. R.; Schmitz, F.; Mevissen, V.; Weiß, S.; Huster, J.; Dronskowski, R.; Langebartels, G.; Autschbach, R.; Zerres, K.; Weber, C.; Hanrath, P.; Hoffmann, R.: The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphism in patients with severe calcifix aortic stenosis. Eur. Heart J. 3 (2004) 512-520.
9. Dorozhkin, S. V.; Epple, M.: Biological and medical significance of calcium phosphates. Angew. Chem. Int. Ed. 41 (2002) 3130-3146.
10. Ikoma, T.; Yamazaki, A.; Nakamura, S.; Akao, M.: Preparation and Structure Refinement of Monoclinic Hydroxyapatite. J. Sol. State Chem. 144 (1999) 272-276.
11. Juan Rodriguez-Carvajal: Program Fullprof 2000. Version 2.10, CEA/Saclay (2002).
12. WinXPow. Stoe Powder Diffraction Software, Stoe & Cie GmbH, Darmstadt, Germany (1998).
13. Sänger, A. T.; Kuhs, W. F.: Structural Disorder in Hydroxyapatite. Z. Kristallogr. 199 (1991) 123-148.